These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2689352)

  • 41. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relapse of gram-negative bacillary meningitis after cefotaxime therapy.
    Bradsher RW
    JAMA; 1982 Sep; 248(10):1214-5. PubMed ID: 6287048
    [No Abstract]   [Full Text] [Related]  

  • 43. The safety and pharmacokinetics of cefotaxime in the treatment of neonates.
    de Louvois J; Mulhall A; Hurley R
    Pediatr Pharmacol (New York); 1982; 2(4):275-84. PubMed ID: 6099886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cefotaxime treatment of meningitis in children.
    Sow A
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():191-4. PubMed ID: 6094439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
    Landesman SH; Corrado ML; Cherubin CC; Gombert M; Cleri D
    Am J Med; 1980 Jul; 69(1):92-8. PubMed ID: 6446240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.
    Steele RW; Eyre LB; Bradsher RW; Weinfeld RE; Patel IH; Spicehandler J
    Antimicrob Agents Chemother; 1983 Feb; 23(2):191-4. PubMed ID: 6301362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hospital-acquired neonatal bacterial meningitis: the impacts of cefotaxime usage on mortality and of amikacin usage on incidence.
    Coovadia YM; Mayosi B; Adhikari M; Solwa Z; van den Ende J
    Ann Trop Paediatr; 1989 Dec; 9(4):233-9. PubMed ID: 2482005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval.
    Kearns GL; Young RA; Jacobs RF
    Clin Pharmacokinet; 1992 Apr; 22(4):284-97. PubMed ID: 1606788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitis.
    Bégué P; Floret D; Mallet E; Raynaud EJ; Safran C; Sarlangues J; Teyssier G
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():161-5. PubMed ID: 6094436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.
    Decazes JM; Ernst JD; Sande MA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):463-7. PubMed ID: 6316841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
    Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
    Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case of neonatal meningitis due to Flavobacterium meningosepticum successfully treated with cefmetazole and cefotaxime].
    Takeda A; Toyoura T; Kiyohara K; Shimohira M; Arai S; Fukuda C
    Jpn J Antibiot; 1988 May; 41(5):557-62. PubMed ID: 3063849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group.
    Peltola H; Anttila M; Renkonen OV
    Lancet; 1989 Jun; 1(8650):1281-7. PubMed ID: 2566824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.
    Odio CM; Faingezicht I; Paris M; Nassar M; Baltodano A; Rogers J; Sáez-Llorens X; Olsen KD; McCracken GH
    N Engl J Med; 1991 May; 324(22):1525-31. PubMed ID: 2027357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cefotaxime in the treatment of meningitis.
    Cherubin CE; LeFrock J
    Infection; 1985; 13 Suppl 1():S68-72. PubMed ID: 4055058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of ceftriaxone with standard therapy for bacterial meningitis.
    Steele RW; Bradsher RW
    J Pediatr; 1983 Jul; 103(1):138-41. PubMed ID: 6306192
    [No Abstract]   [Full Text] [Related]  

  • 57. Cefotaxime for treatment of gram-negative bacterial meningitis in infants and children.
    Feldstein TJ; Uden DL; Larson TA
    Pediatr Infect Dis J; 1987 May; 6(5):471-5. PubMed ID: 3601495
    [No Abstract]   [Full Text] [Related]  

  • 58. Neonatal gram negative meningitis: a 10-year review, with reference to outcome and relapse of infection.
    Anderson SG; Gilbert GL
    J Paediatr Child Health; 1990 Aug; 26(4):212-6. PubMed ID: 2257183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children.
    Jacobs RF; Wells TG; Steele RW; Yamauchi T
    J Pediatr; 1985 Jul; 107(1):129-33. PubMed ID: 3847486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous cefotaxime in children with bacterial meningitis.
    Belohradsky BH; Bruch K; Geiss D; Kafetzis D; Marget W; Peters G
    Lancet; 1980 Jan; 1(8159):61-3. PubMed ID: 6101414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.